Camps J - Search Results

1

Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases.

Riezu-Boj JI, Parker D, Civeira MP, Phippard D, Corbishley TP, Camps J, Castilla A, Prieto J. Riezu-Boj JI, et al. Among authors: camps j. J Hepatol. 1992 Jul;15(3):309-13. doi: 10.1016/0168-8278(92)90061-s. J Hepatol. 1992. PMID: 1280288 Free article.

2

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy.

Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Qian C, et al. Among authors: camps j. J Hepatol. 1992 Nov;16(3):380-3. doi: 10.1016/s0168-8278(05)80674-9. J Hepatol. 1992. PMID: 1336787

3

[Detection of hepatitis B virus DNA in serum by gene amplification in patients with chronic hepatitis B and in patients chronic hepatitis C].

Jáuregui JI, Civeira MP, Serrano M, Camps J, Castilla A, Riezu-Boj JI, Prieto J. Jáuregui JI, et al. Among authors: camps j. Med Clin (Barc). 1992 Jan 18;98(2):49-52. Med Clin (Barc). 1992. PMID: 1545620 Spanish.

4

Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effects of alcohol intake cessation.

Camps J, Pizarro I, Prats E, La Ville A, Turner PR, Masana L, Joven J. Camps J, et al. J Hepatol. 1994 Nov;21(5):704-9. doi: 10.1016/s0168-8278(94)80227-0. J Hepatol. 1994. PMID: 7890883

5

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

Camps J, Crisóstomo S, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Camps J, et al. Gut. 1993 Dec;34(12):1714-7. doi: 10.1136/gut.34.12.1714. Gut. 1993. PMID: 7904252 Free PMC article.

6

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.

Camps J, García-Granero M, Riezu-Boj JI, Larrea E, de Alava E, Civeira MP, Castilla A, Prieto J. Camps J, et al. J Hepatol. 1994 Jul;21(1):4-11. doi: 10.1016/s0168-8278(94)80129-0. J Hepatol. 1994. PMID: 7963420 Free article. Clinical Trial.

7

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon.

Camps J, García N, Riezu-Boj JI, Civeira MP, Prieto J. Camps J, et al. J Hepatol. 1993 Nov;19(3):408-12. doi: 10.1016/s0168-8278(05)80550-1. J Hepatol. 1993. PMID: 8151102

8

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia.

Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Camps J, et al. J Hepatol. 1993 Mar;17(3):390-6. doi: 10.1016/s0168-8278(05)80223-5. J Hepatol. 1993. PMID: 8391042 Clinical Trial.

9

Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.

de Alava E, Camps J, Pardo-Mindán J, García-Granero M, Muñoz M, Sola J, Civeira MP, Contreras F, Vázquez JJ, Castilla A, et al. de Alava E, et al. Among authors: camps j. Liver. 1993 Apr;13(2):73-9. doi: 10.1111/j.1600-0676.1993.tb00610.x. Liver. 1993. PMID: 8510490 Clinical Trial.

10

Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.

Ferré N, Marsillach J, Camps J, Mackness B, Mackness M, Riu F, Coll B, Tous M, Joven J. Ferré N, et al. Among authors: camps j. J Hepatol. 2006 Jul;45(1):51-9. doi: 10.1016/j.jhep.2005.12.018. Epub 2006 Feb 6. J Hepatol. 2006. PMID: 16510204

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters